VCM
BDSI

Versant Capital Management’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Versant Capital Management’s Portfolio BDSI Stock Details BDSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-50
Closed – – 1712
2021
Q4 		$0 Hold
50
– – ﹤0.01% 1659
2021
Q3 		$0 Hold
50
– – ﹤0.01% 1678
2021
Q2 		$0 Hold
50
– – ﹤0.01% 1680
2021
Q1 		$0 Hold
50
– – ﹤0.01% 1659
2020
Q4 		$0 Hold
50
– – ﹤0.01% 1639
2020
Q3 		$0 Hold
50
– – ﹤0.01% 1621
2020
Q2 		$0 Hold
50
– – ﹤0.01% 1693
2020
Q1 		$0 Buy
+50
New +$246 ﹤0.01% 1883

Other funds holding BDSI

CAM
Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return
FCMT
Founders Capital Management (Texas) Houston, Texas $231M AUM 61.68% 1-Year Est. Return

Versant Capital Management's BDSI Position: Q1 2022 in Review

Versant Capital Management sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2022, closing a stake of 50 shares.

Versant Capital Management first reported a position in BDSI in Q1 2020 and held it in 8 quarters. The position peaked at $0 in Q4 2021. 2 funds tracked by Wall St. Rank hold BDSI as of Q1 2022.

  • Versant Capital Management reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2022 after selling out during the quarter.
  • Versant Capital Management sold 50 BioDelivery Sciences International, Inc. shares in Q1 2022.
  • Versant Capital Management first reported a position in BioDelivery Sciences International, Inc. in Q1 2020 and held it in 8 quarters.
  • Versant Capital Management's BioDelivery Sciences International, Inc. position peaked at $0 in Q4 2021.
  • 2 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2022.

Based on Versant Capital Management's 13F filing for Q1 2022, filed 29 Apr 2022.